Zimmer Biomet Holdings, Inc. (ZBH)
NYSE: ZBH · Real-Time Price · USD
93.79
-1.36 (-1.43%)
At close: Jul 11, 2025, 4:00 PM
93.79
0.00 (0.00%)
After-hours: Jul 11, 2025, 4:50 PM EDT
Zimmer Biomet Holdings Market Cap
Zimmer Biomet Holdings has a market cap or net worth of $18.56 billion as of July 11, 2025. Its market cap has decreased by -16.84% in one year.
Market Cap
18.56B
Enterprise Value
24.57B
1-Year Change
-16.84%
Ranking
Category
Stock Price
$93.79
Market Cap Chart
Since July 25, 2001, Zimmer Biomet Holdings's market cap has increased from $5.76B to $18.56B, an increase of 222.05%. That is a compound annual growth rate of 5.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2025 | 18.83B | -10.48% |
| Dec 31, 2024 | 21.03B | -17.32% |
| Dec 29, 2023 | 25.43B | -4.95% |
| Dec 30, 2022 | 26.76B | 0.82% |
| Dec 31, 2021 | 26.54B | -16.91% |
| Dec 31, 2020 | 31.94B | 3.74% |
| Dec 31, 2019 | 30.79B | 45.52% |
| Dec 31, 2018 | 21.16B | -13.41% |
| Dec 29, 2017 | 24.43B | 18.20% |
| Dec 30, 2016 | 20.67B | -1.12% |
| Dec 31, 2015 | 20.91B | 8.84% |
| Dec 31, 2014 | 19.21B | 20.55% |
| Dec 31, 2013 | 15.93B | 37.77% |
| Dec 31, 2012 | 11.57B | 20.83% |
| Dec 30, 2011 | 9.57B | -9.69% |
| Dec 31, 2010 | 10.60B | -15.81% |
| Dec 31, 2009 | 12.59B | 38.69% |
| Dec 31, 2008 | 9.08B | -41.54% |
| Dec 31, 2007 | 15.53B | -16.99% |
| Dec 29, 2006 | 18.71B | 11.94% |
| Dec 30, 2005 | 16.71B | -14.98% |
| Dec 31, 2004 | 19.65B | 15.44% |
| Dec 31, 2003 | 17.02B | 110.23% |
| Dec 31, 2002 | 8.10B | 36.81% |
| Dec 31, 2001 | 5.92B | 2.73% |
View and export this data all the way back to 2001.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 698.13B |
| Johnson & Johnson | 374.84B |
| AbbVie | 335.21B |
| Novo Nordisk | 313.36B |
| UnitedHealth Group | 279.13B |
| Novartis AG | 240.15B |
| Abbott Laboratories | 232.02B |
| AstraZeneca | 217.48B |